This site is intended for healthcare professionals only
LoginRegister

Diabetes and Endocrinology Dialogues

Obesity

Tirzepatide consistently reduces bodyweight regardless of BMI before treatment, shows new analysis

Tirzepatide, a medication authorised to treat obesity and/or type 2 diabetes, consistently reduces bodyweight regardless of the patient's body mass...
View All

Latest News and Guidelines

Evergreen Talk Series: How can Safety and Tolerability of Linagliptin and Dapagliflozin benefit diverse T2DM population?

Evergreen Talk Series: How can Safety and Tolerability of Linagliptin and Dapagliflozin benefit...

Sugary drinks, fruit juices linked to higher risk of developing Type 2 diabetes among boys: Study

Sugary drinks, fruit juices linked to higher risk of developing Type 2 diabetes among boys: Study

Intermittent fasting increases the risk of death from cardiovascular causes? Study sparks debate

Intermittent fasting increases the risk of death from cardiovascular causes? Study sparks debate

Ketogenic Diet Reduces Inflammation in Psoriasis and Psoriatic Arthritis Patients: Study

Ketogenic Diet Reduces Inflammation in Psoriasis and Psoriatic Arthritis Patients: Study

Novo Nordisk Bets on Oral Wegovy to Take on Eli Lilly in US Obesity Market

Novo Nordisk Awiqli recommended for approval for diabetes by European regulatory authorities

Liraglutide can prevent PAD progression in patients with type 2 diabetes: STARDUST trial

Liraglutide can prevent PAD progression in patients with type 2 diabetes: STARDUST trial

View All
X